Keith Katkin - 01 May 2023 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/Keith Katkin
Issuer symbol
ELDN
Transactions as of
01 May 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 18:45:57 UTC
Previous filing
03 Feb 2023
Next filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (right to buy) Award $0 +752,185 $0.000000 752,185 01 May 2023 Common Stock 752,185 $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 752,185 shares of Common Stock, which option vests with respect to 376,093 shares on May 1, 2024 and with respect to 376,092 shares on May 1, 2025.